Order Article Reprints

Vecchiotti D, Verzella D, Di Vito Nolfi M, D’Andrea D, Flati I, Di Francesco B, Cornice J, Alesse E, Capece D, Zazzeroni F. Elevated NF-κB/SHh/GLI1 Signature Denotes a Worse Prognosis and Represent a Novel Potential Therapeutic Target in Advanced Prostate Cancer. Cells. 2022; 11(13):2118. https://doi.org/10.3390/cells11132118

Vecchiotti, Davide, Daniela Verzella, Mauro Di Vito Nolfi, Daniel D’Andrea, Irene Flati, Barbara Di Francesco, Jessica Cornice, Edoardo Alesse, Daria Capece, and Francesca Zazzeroni. 2022. "Elevated NF-κB/SHh/GLI1 Signature Denotes a Worse Prognosis and Represent a Novel Potential Therapeutic Target in Advanced Prostate Cancer" Cells 11, no. 13: 2118. https://doi.org/10.3390/cells11132118

Vecchiotti, D., Verzella, D., Di Vito Nolfi, M., D’Andrea, D., Flati, I., Di Francesco, B., Cornice, J., Alesse, E., Capece, D., & Zazzeroni, F. (2022). Elevated NF-κB/SHh/GLI1 Signature Denotes a Worse Prognosis and Represent a Novel Potential Therapeutic Target in Advanced Prostate Cancer. Cells, 11(13), 2118. https://doi.org/10.3390/cells11132118